International Healthcare Pricing Intelligence
Verified procedure-level pricing from JCI-accredited international hospitals, licensable for domestic provider negotiation, plan design benchmarking, stop-loss underwriting, and fiduciary cost evaluation.
Schedule a BriefingWhat the Data Contains
Procedure-level pricing collected directly from hospitals holding JCI accreditation or equivalent national accreditation. Prices are provider-listed, not estimated. These are published rates from real facilities, not modelled projections or survey averages.
The dataset includes procedure pricing with CPT code mapping where applicable, facility accreditation status, and date of last confirmation. Coverage is country-agnostic with signed hospital partnerships across multiple regions and expansion underway across Latin America, the Middle East, Southeast Asia, and Eastern Europe.
The scope and granularity of the data available for a specific licensing engagement is best understood through the live platform. A briefing includes a walkthrough of the dataset as it exists today and the roadmap for clinical outcomes data (surgeon-level outcomes, complication rates, Patient-Reported Outcome Measures) through partnerships currently in development.
Institutional Applications
The same pricing data serves different analytical requirements depending on the buyer. The core mechanism is identical: verified international procedure pricing provides an external reference point for evaluating domestic healthcare costs.
Insurers and MA Plans. Negotiation input for domestic hospital contract renewals. Reference pricing that creates structural pressure on domestic rates without requiring any member to travel.
Self-Funded Employers. Benchmark current plan costs against international alternatives. Supports ERISA fiduciary documentation of cost-reasonableness evaluation.
TPAs and Plan Administrators. Enhanced benchmarking capabilities for employer clients. Differentiation against competing administrators through proprietary pricing intelligence.
Benefits Consultants and Brokers. Reference tool for employer renewal conversations. Pricing intelligence that competing advisory firms don't have access to.
Stop-Loss Carriers. Underwriting data for plans with international pricing access. Projected claim cost modelling using verified international facility rates.
Health Systems and Providers. Competitive positioning analysis. Benchmark own pricing against international equivalents for the same procedures at equivalent accreditation standards.
The Reference Pricing Mechanism
The institutional value of international pricing data doesn't depend on patients travelling abroad. Two documented cases establish the mechanism.
CalPERS introduced reference pricing for joint replacements. 85% of the savings came from domestic hospitals voluntarily reducing their prices to remain competitive (Robinson and Brown, Health Affairs, 2013). Patients didn't need to choose the cheaper option. The existence of a visible, credible alternative restructured the pricing dynamic. Hospitals that had charged $50,000+ for joint replacements reduced their rates to remain within the CalPERS reference threshold.
Hannaford Bros. offered international surgical options through an Aetna partnership. Zero employees travelled abroad. Within weeks, two New England hospitals called offering 60% discounts to retain volume. The international option was never used. It didn't need to be. The reference price did the work.
The conclusion is structural: verified international pricing creates competitive pressure on domestic rates whether or not a single patient travels. The reference price needs to exist and be credible. The pricing intelligence product provides that reference price at procedure level, facility level, and accreditation level.
Structural Differentiation from Domestic Transparency Data
Domestic price transparency data reveals variance within the US system. Hospital A charges $45,000 and Hospital B charges $55,000 for the same procedure. The negotiation leverage from this data is limited: both hospitals can cite market-specific factors, case complexity, payer mix, and regional cost-of-living differences to justify their rates. The pricing gap between domestic institutions is narrow enough to be explained away.
International pricing data reveals the structural gap. The same procedure at a JCI-accredited facility, meeting equivalent institutional accreditation standards, costs $12,000. The differential is 70-80%, not 10-20%. Domestic hospitals cannot dispute the accreditation equivalence (JCI is the international arm of the Joint Commission that accredits US hospitals). They cannot dispute the pricing (it's published by the facility). The only response is to reduce their own pricing to a level where the differential no longer motivates the conversation.
The negotiation leverage per data point is fundamentally different. Domestic benchmarks create incremental pressure. International benchmarks create structural pressure. The CalPERS evidence demonstrates that structural pressure produces the majority of savings.
Integration Options
Integration is scoped during the licensing conversation. Four delivery mechanisms are available, each designed for minimal friction.
Data Feed. Structured pricing data delivered via API or scheduled export, formatted for integration into existing contracting and analytics systems.
Benchmarking Reports. Custom procedure-level comparisons for specific plan populations, delivered as analyst-ready documents.
Platform Access. Direct access to the pricing database through a dedicated enterprise portal.
Embedded Widget. White-label pricing comparison tool embeddable in employer benefits portals or consultant platforms.
No BAA required. No patient data involved. No HIPAA obligations. No vendor security review. Integration timeline is measured in days, not months.
Credibility
Frequently Asked Questions
Structured pricing data is available via API, scheduled export (CSV/JSON), analyst-ready benchmarking reports (PDF/Excel), direct platform access through a dedicated enterprise portal, or as a white-label pricing comparison widget embeddable in employer benefits portals or consultant platforms. Format and delivery mechanism are determined during the scoping conversation.
International prices are updated as providers submit new pricing to the marketplace. The dataset undergoes a full refresh quarterly. Update frequency reflects the nature of international hospital pricing: rates change less frequently than domestic negotiated rates because they are published prices, not contract terms.
No. The dataset is entirely aggregate facility-level pricing. It contains procedure names, facility details, accreditation status, and published prices. There are no patient records, claims data, member rosters, or identifiable health information. No BAA is required. No HIPAA obligations arise. No vendor security review is needed. Integration timeline is measured in days, not months.
Domestic transparency data shows variance within the US system: one hospital charges $45,000 and another charges $55,000 for the same procedure. International pricing data reveals the structural gap: the same procedure at a JCI-accredited facility costs $12,000. Domestic hospitals can dispute benchmarks from peer institutions citing market differences, case complexity, or payer mix. They cannot dispute that the procedure is performed at equivalent accreditation standards for 70% less at a facility overseas.
The dataset methodology and its application to US healthcare cost analysis are the subject of a peer-reviewed paper co-authored with a US congressional health policy advisor, accepted for publication in Health Affairs Scholar. The platform and its pricing data have been cited as a reference source by Microsoft Copilot, Google AI Overviews, and competitor healthcare pricing platforms.
The dataset is country-agnostic. Current coverage spans signed hospital partnerships across multiple regions, with expansion underway across Latin America, the Middle East, Southeast Asia, and Eastern Europe. All listed facilities hold JCI accreditation or equivalent national accreditation. Specific country and facility coverage is discussed during the licensing conversation.
Current data covers procedure-level pricing, facility accreditation status, and provider profiles. Future additions through clinical outcomes partnerships will include surgeon-level outcome data, complication rates, and Patient-Reported Outcome Measures (PROMs). The timeline for outcomes data availability is discussed during the scoping conversation.
Licensing, Integration, or Sample Dataset
Contact the institutional team directly.
Sylk Health operates an online marketplace listing JCI or equivalent nationally accredited international healthcare providers. Sylk Health is not a healthcare provider, insurance company, health plan, or clinical service. Sylk Health does not provide medical advice, coordinate care, arrange travel, or manage clinical outcomes. All providers listed on the marketplace are independent entities. Patients contract directly with providers. Provider-listed prices are published by the providers themselves and may change without notice. Sylk Health does not set, verify, or guarantee provider pricing. Actual costs depend on individual case complexity, provider selection, and treatment requirements. Content on this page is for informational purposes only and does not constitute medical, legal, actuarial, or fiduciary advice. Plan administrators, carriers, and healthshare ministries should consult their own qualified advisors before making decisions based on information presented here. Sylk Health has no affiliation with any third-party organisation referenced on this page unless explicitly stated.